China Pharma (CPHI) vs Veru (VERU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Veru (VERU) has outperformed China Pharma (CPHI) over the past year, losing 45.1% versus a loss of 51.8%. Over five years, VERU leads with a -97.2% price change compared with -99.7% for CPHI. China Pharma is the larger company by market cap ($41.3 million vs $41.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPHI | VERU |
|---|---|---|
| Share price | $0.96 | $2.42 |
| Market cap | $41.30M | $41.26M |
| 1-day change | +12.94% | -1.63% |
| YTD return | -20.66% | +13.08% |
| 1-year return | -51.76% | -45.12% |
| 5-year return | -99.65% | -97.18% |
| EPS (TTM) | $-0.42 | $-0.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.19 | $7.33 |
| 52-week low | $0.38 | $2.05 |
| Distance from 52-week high | -95.00% | -66.98% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +960.74% |
| Average volume | 5.81M | 242.06K |
| Shares outstanding | 43.02M | 17.05M |
| Employees | 215 | 20 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About China Pharma
CPHI stock →China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China.
Healthcare · Drug Manufacturers - Specialty & Generic · 215 employees
About Veru
VERU stock →Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
Healthcare · Biotechnology · 20 employees
CPHI vs VERU FAQ
Which is bigger, China Pharma or Veru?
China Pharma (CPHI) is larger, with a market capitalization of $41.30M compared with $41.26M for Veru (VERU).
Which stock has performed better over the past year, CPHI or VERU?
VERU returned -45.12% over the past 12 months, compared with -51.76% for CPHI (price return, excluding dividends). Past performance does not predict future results.
Are China Pharma and Veru in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for China Pharma and Biotechnology for Veru.